We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+40.24%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$356M
AUM Growth
+$164M
Cap. Flow
+$115M
Cap. Flow %
32.2%
Top 10 Hldgs %
50.6%
Holding
52
New
19
Increased
13
Reduced
10
Closed
8

Top Buys

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$20.1M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$13.7M
3
RVNC
Revance Therapeutics, Inc.
RVNC
+$7.91M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$7.48M
5
ALT icon
Altimmune
ALT
+$6.42M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
+$5.7M
2
MRUS
Merus
MRUS
+$5.66M
3
FOLD
Amicus Therapeutics
FOLD
+$5.57M
4
ARVN icon
Arvinas
ARVN
+$4.63M
5
COGT icon
Cogent Biosciences
COGT
+$4.11M

Sector Composition

1 Healthcare 68.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DICE
51
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-30,000
Closed -$547K
NMTR
52
DELISTED
9 Meters Biopharma
NMTR
– –
-90,000
Closed -$469K
1 2
3

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Ghost Tree Capital held 52 positions worth $356M, up 86% from $192M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Ghost Tree Capital deployed $115M of net new capital in Q3 2022, opening 19 new positions and adding to 13 existing holdings. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 725,000 shares worth $18.2M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 76% a quarter earlier.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $5.57M trimmed.

  • Ghost Tree Capital's largest Q3 2022 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 725,000 shares worth $18.2M.
  • Ghost Tree Capital added most to CTI BioPharma Corp. (DE) Common Stock in Q3 2022, an estimated $7.48M increase.
  • Ghost Tree Capital's biggest Q3 2022 reduction was Amicus Therapeutics, cutting an estimated $5.57M.
  • Ghost Tree Capital fully exited Seagen Inc. Common Stock in Q3 2022, selling an estimated $5.7M.
  • Ghost Tree Capital's ten largest holdings make up 51% of its $356M portfolio in Q3 2022.
  • Ghost Tree Capital opened 19 new positions and closed 8 in Q3 2022.
  • Ghost Tree Capital's portfolio value rose 86% quarter-over-quarter to $356M.

Based on Ghost Tree Capital's 13F filing for Q3 2022, filed 14 Nov 2022.